CVBF vs RARE · P/E 14, rev $351.2M vs rev $350.0M
CVB Financial Corporation (CVBF) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
CVB Financial Corporation (CVBF) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CVBF revenue for 2026-06-30 was $351.2M. Net income was $99.3M. CVBF currently screens at market cap $2.71B and trailing P/E 13.6.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CVBF currently screens at market cap $2.71B and trailing P/E 13.6. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CVBF and RARE stock pages for the full models.
Not investment advice.